Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Cibus, Inc.
SIC 2870 · Agricultural Chemicals
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Cibus, Inc.
SIC 2870 · Agricultural Chemicals
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Cibus, Inc.
SIC 2870 · Agricultural Chemicals
Notes
Support
about
terms
$
CBUS
Cibus, Inc.
CIK:
0001705843
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:
Total revenue
$ 994
$ 933
$ 2,675
$ 1,967
Operating expenses:
Research and development
8,506
12,228
17,223
24,027
Selling, general, and administrative
5,413
6,651
10,497
16,507
Goodwill impairment
0
0
0
20,950
Total operating expenses
13,919
18,879
27,720
61,484
Loss from operations
(12,925)
(17,946)
(25,045)
(59,517)
Royalty liability interest expense - related parties
(9,475)
(8,668)
(18,596)
(17,045)
Other interest income, net
111
106
139
225
Non-operating income (expense), net
150
(23)
148
416
Loss before income taxes
(22,139)
(26,531)
(43,354)
(75,921)
Income tax expense
(6)
(27)
(13)
(29)
Net loss
(22,145)
(26,558)
(43,367)
(75,950)
Net loss attributable to noncontrolling interest
0
(1,186)
0
(3,692)
Net loss attributable to Cibus, Inc. stockholders
$ (22,145)
$ (25,372)
$ (43,367)
$ (72,258)
Basic net loss per share of Class A common stock (in dollars per share)
$ (0.29)
$ (0.61)
$ (0.61)
$ (1.88)
Diluted net loss per share of Class A common stock (in dollars per share)
$ (0.29)
$ (0.61)
$ (0.61)
$ (1.88)
Weighted average shares of Class A common stock outstanding - basic (in shares)
76,755,936
41,618,893
71,011,006
38,353,931
Weighted average shares of Class A common stock outstanding - diluted (in shares)
76,755,936
41,618,893
71,011,006
38,353,931
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities
Net loss
$ (43,367)
$ (75,950)
Adjustments to reconcile net loss to net cash used in operating activities:
Royalty liability interest expense - related parties
18,596
17,045
Goodwill impairment
0
20,950
Depreciation and amortization
2,359
3,209
Stock-based compensation
3,055
4,477
Loss on disposal of assets, net
4
80
Change in fair value of liability classified Class A common stock warrants
(41)
(455)
Other
(2)
49
Changes in operating assets and liabilities:
Accounts receivable
(335)
88
Prepaid expenses and other current assets
149
(44)
Accounts payable
(907)
82
Accrued expenses
(86)
3,998
Accrued compensation
(463)
(213)
Deferred revenue
88
(17)
Right-of-use assets and lease obligations, net
(95)
1,141
Other assets and liabilities, net
151
129
Net cash used in operating activities
(20,894)
(25,431)
Investing activities
Proceeds from sales of property, plant, and equipment
43
0
Purchases of property, plant, and equipment
(73)
(384)
Net cash used in investing activities
(30)
(384)
Financing activities
Proceeds from issuances of securities
37,260
50,100
Costs paid related to issuances of securities
(5,357)
(1,951)
Payment of taxes related to restricted stock units withheld from employees
(115)
(39)
Repayments of notes payable
(352)
(279)
Net cash provided by financing activities
31,436
47,831
Effect of exchange rate changes on cash and cash equivalents
(6)
14
Net increase in cash and cash equivalents
10,506
22,030
Cash and cash equivalents – beginning of period
9,923
14,433
Cash and cash equivalents – end of period
$ 20,429
$ 36,463
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets:
Cash and cash equivalents
$ 20,429
$ 9,923
Accounts receivable
838
503
Prepaid expenses and other current assets
2,189
1,643
Total current assets
23,456
12,069
Property, plant, and equipment, net
4,919
6,300
Operating lease right-of-use assets
21,015
21,557
Intangible assets, net
30,770
31,679
Goodwill
232,516
232,516
Other non-current assets
771
926
Total assets
313,447
305,047
Current liabilities:
Accounts payable
5,612
8,070
Accrued expenses
1,893
1,946
Accrued compensation
2,606
3,061
Deferred revenue
627
536
Current portion of notes payable
812
435
Current portion of operating lease obligations
2,859
2,731
Class A common stock warrants
38
79
Total current liabilities
14,447
16,858
Notes payable, net of current portion
53
93
Operating lease obligations, net of current portion
29,018
29,783
Royalty liability - related parties
253,519
234,923
Other non-current liabilities
1,608
1,561
Total liabilities
298,645
283,218
Commitments and contingencies (See Note 8)
Stockholders’ equity:
Additional paid-in capital
918,639
882,171
Class A common stock in treasury, at cost; 249,317 shares as of June 30, 2026, and 193,195 shares as of December 31, 2025
(2,256)
(2,141)
Accumulated deficit
(901,618)
(858,251)
Accumulated other comprehensive income
24
39
Total stockholders’ equity
14,802
21,829
Total liabilities and stockholders’ equity
313,447
305,047
Common Class A
Stockholders’ equity:
Common stock
13
11
Common Class B
Stockholders’ equity:
Common stock
$ 0
$ 0